Merck News - MRK

Kaufen
Verkaufen
Best deals to access real time data!
Trade Alert US
Monthly Subscription
for only
52,79 €
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
US Markets and Indices (NYSE/NASDAQ/AMEX/DowJones/S&P)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp ISIN Beschreibung
Merck MRK NYSE Ordinary Share
  Änderung Änderung % Aktuell Hoch Niedrig Handelsbeginn Handelsende Zeit
  -0,12 -0,14% 82,78 83,37 82,46 82,80 82,90 05:59:54
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
15.6.201909:02DJNDrug Firms Sue Over Ad Rule -- WSJ
15.6.201900:27DJNDrugmakers Sue to Block Federal Rule Requiring Drug Prices..
13.6.201914:05PRNUSIBM, KPMG, Merck and Walmart to collaborate as part of FDA's..
11.6.201912:45BWFDA Approves Two New Indications for Merck’s KEYTRUDA®..
10.6.201913:37DJNMerck to Buy Tilos Therapeutics for Up to $773 Million
10.6.201912:45BWMerck to Acquire Tilos Therapeutics
04.6.201923:22EDGARStatement of Changes in Beneficial Ownership (4)
04.6.201923:21EDGARStatement of Changes in Beneficial Ownership (4)
04.6.201923:21EDGARStatement of Changes in Beneficial Ownership (4)
04.6.201923:21EDGARStatement of Changes in Beneficial Ownership (4)
04.6.201923:20EDGARStatement of Changes in Beneficial Ownership (4)
04.6.201923:20EDGARStatement of Changes in Beneficial Ownership (4)
04.6.201923:20EDGARStatement of Changes in Beneficial Ownership (4)
04.6.201923:20EDGARStatement of Changes in Beneficial Ownership (4)
04.6.201923:19EDGARStatement of Changes in Beneficial Ownership (4)
04.6.201923:19EDGARStatement of Changes in Beneficial Ownership (4)
04.6.201923:19EDGARStatement of Changes in Beneficial Ownership (4)
03.6.201922:55BWFDA Approves Merck’s ZERBAXA® (ceftolozane & tazobactam) 3g..
03.6.201922:15BWLYNPARZA® (olaparib) Phase 3 SOLO3 Trial Demonstrated a 72%..
03.6.201908:48DJNAstraZeneca Lynparza Trial Results 'Unprecedented'
02.6.201913:30BWLYNPARZA® (olaparib) First-Line Maintenance Therapy Nearly..
01.6.201913:30BWFive-Year Survival Data for Merck’s KEYTRUDA®..
31.5.201916:56EDGARCurrent Report Filing (8-k)
31.5.201912:45BWMerck’s KEYTRUDA® (pembrolizumab) Demonstrates Improved..
29.5.201920:30DJNJohnson & Johnson Weighs on Pharmaceutical ETFs
28.5.201922:05BWMerck Announces Third-Quarter 2019 Dividend
23.5.201916:44EDGARSpecialized Disclosure Report (sd)
22.5.201914:00BWMerck Foundation Announces Grant to American Cancer Society..
21.5.201915:46DJNMerck to Buy Cancer Drug Maker Peloton Therapeutics -- 2nd..
21.5.201914:23DJNMerck to Buy Cancer Drug Maker Peloton Therapeutics --..
21.5.201914:00DJNMerck to Buy Peloton Therapeutics
21.5.201912:45BWMerck to Acquire Peloton Therapeutics, Bolstering Oncology..
21.5.201900:51DJNCourt Rules Judge, not Jury, Should Rule on Merck Fosamax..
20.5.201923:24DJNMerck Says Keytruda Didn't Meet Primary Endpoint in..
20.5.201922:30BWMerck Provides Update on Phase 3 KEYNOTE-119 Study of..
20.5.201920:20DJNSupreme Court Asks Lower Court to Reconsider Merck Ruling..
15.5.201923:00BWNew Research from Merck’s Broad Oncology Clinical..
13.5.201923:08EDGARStatement of Changes in Beneficial Ownership (4)
13.5.201923:07EDGARStatement of Changes in Beneficial Ownership (4)
13.5.201923:07EDGARStatement of Changes in Beneficial Ownership (4)
13.5.201923:06EDGARStatement of Changes in Beneficial Ownership (4)
10.5.201900:13EDGARStatement of Changes in Beneficial Ownership (4)
10.5.201900:13EDGARStatement of Changes in Beneficial Ownership (4)
09.5.201913:00BWKatie Couric Joins Merck & Cancer Advocates to Support..
08.5.201922:39EDGARQuarterly Report (10-q)
08.5.201915:56DJNMerck V114 Vaccine Meets Primary Endpoint in Phase 2 Study
08.5.201915:00BWMerck Announces Results from Phase 2 Trial of..
08.5.201901:42EDGARStatement of Changes in Beneficial Ownership (4)
08.5.201901:42EDGARStatement of Changes in Beneficial Ownership (4)
08.5.201901:42EDGARStatement of Changes in Beneficial Ownership (4)
Mehr News über diese Aktie »
Kürzlich von Ihnen besucht
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20190616 04:43:53